Martin F. Haslanger

Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

Martin L. Ogletree, Don N. Harris, R Greenberg et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 333 citations

SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.

Edmund J. Sybertz, Peter J.S. Chiu, Subbarao Vemulapalli et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 113 citations

Mechanism of Cholesteryl Ester Transfer Protein Inhibition by a Neutralizing Monoclonal Antibody and Mapping of the Monoclonal Antibody Epitope

T L Swenson, C B Hesler, M L Brown et al. · Journal of Biological Chemistry · 1989 · 81 citations · Full text

Immunocytochemical Technique, Immunology, Immunodominance +22

Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.

Edmund J. Sybertz, Peter J.S. Chiu, Subbarao Vemulapalli et al. · Hypertension · 1990 · 64 citations

Molecular Pharmacology, Hypertension, Cardiovascular Disease +15

A novel α-alkylation of α,β-epoxy ketones

E. J. Corey, Lawrence S. Melvin, Martin F. Haslanger · Tetrahedron Letters · 1975 · 46 citations

Engineering, Organic Chemistry, β-Epoxy Ketones +4